资讯

Biotechnology company Regeneron buying 23andMe for $256 million
Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing ...
After US cuts funding, WHO chief defends $2.1B budget request by comparing it with cost of war
WHO has presented a budget for the next two years that is 22% less than originally planned, largely in response to U.S. and ...